A CRISPR/dCasX-mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c-MYC or activating TP53.
作者信息
Cao Congcong, Yao Lin, Li Aolin, Zhang Quan, Zhang Zhenan, Wang Xiaofei, Gan Ying, Liu Yuchen, Zhang Qian
机构信息
Department of Urology, Peking University First Hospital, Beijing, China.
Institute of Urology, Peking University, Beijing, China.
出版信息
Clin Transl Med. 2021 Sep;11(9):e537. doi: 10.1002/ctm2.537.
Abstract
摘要
Zotero 插件